What is the success rate of stem cell therapy for Psoriasis?
A reliable success rate for psoriasis cell therapy is not established. PASI improvement, complete or near-complete clearance, symptom relief and remission duration are different endpoints and should not be merged. Provider percentages from uncontrolled cohorts should not be used to predict an individual result. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
What the evidence shows for Psoriasis
Human psoriasis studies of MSCs and related products are small and heterogeneous. Changes in PASI components, symptoms or biomarkers have not established comparative efficacy against modern approved systemic treatments. Cross-study comparisons with anti-TNF, anti-IL-17 or anti-IL-23 medicines are not reliable without appropriate randomised controls. No pooled response rate is published here because product, dose, route, comparator and follow-up differ too widely for a single figure to be meaningful. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
Am I a candidate? → · Psoriasis: full overview → · Psoriasis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.